midi glp 1 cost comparison for GLP-1 agonist Self Pay Daily GLP-1 Support – Midi
Description
Wegovy is administered as a once-weekly subcutaneous injection, with dosing gradually escalated over 16-20 weeks to minimise gastrointestinal side effects
The idea is that this combines the anorectic and insulinotropic activities of GLP-1 and GIP with the energy expenditure effect of glucagon
PMCID: PMC8998470
Despite outstanding outcomes and promising new developments, the possibility of regaining weight is very real and could even occur four times faster than when stopping exercise and healthy eating
These findings align with what researchers observe when studying GLP-1 and GIP agonist side effect profiles
